DNM1L and Huntington disease: Indeed, Drp1 inhibition has been reported by independent laboratories to reduce protein aggregation in experimental models of PD [12, 13], AD [14, 15] and HD [16], indicating the potential involvement of protein removal pathways such as autophagy.